Hays Advisory’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
2016
Q4
$4.8M Sell
2016
Q3
$6.46M Sell
2016
Q2
$5.61M Buy